Basics Travere Therapeutics, Inc. IPO Date: August 15, 2003 Sector: Healthcare Industry: Biotech Market Cap: $1.93B Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 2.56% Avg Daily Range (30 D): $0.47 | 2.65% Avg Daily Range (90 D): $0.44 | 2.55% Institutional Daily Volume Avg Daily Volume: .93M Avg Daily Volume (30 D): 1.45M Avg Daily Volume (90 D): 1.34M Trade Size Avg Trade Size (Sh.): 83 Avg Trade Size (Sh.) (30 D): 73 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 3,227 Avg Inst. Trade: $2.03M Avg Inst. Trade (30 D): $2.41M Avg Inst. Trade (90 D): $2.48M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.87M Avg Closing Trade (30 D): $3.31M Avg Closing Trade (90 D): $3.75M Avg Closing Volume: 171.72K     News Mar 17, 2025 @ 11:01 AM Travere Therapeutics Submits sNDA to FDA for Appro... Source: N/A Feb 12, 2025 @ 10:30 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Jan 6, 2025 @ 9:30 PM Travere Therapeutics to Present at the 43rd Annual... Source: N/A Nov 13, 2024 @ 10:00 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Nov 8, 2024 @ 2:05 AM Travere Therapeutics Announces Pricing of Public O... Source: Globe Newswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.14 $-.47 Diluted EPS $-.14 $-.47 Revenue $ $ 114.45M $ 81.73M Gross Profit $ $ 112.93M $ 77.05M Net Income / Loss $ $ -12.76M $ -41.23M Operating Income / Loss $ $ -12.65M $ -42.67M Cost of Revenue $ $ 1.52M $ 4.68M Net Cash Flow $ $ 13.26M $ 3.36M PE Ratio     Splits Nov 08, 2011:   1:9